Invuity’s patented Intelligent Photonics® devices provide direct visualization of the surgical cavity enabling enhanced precision, efficiency and safety. Our technology is integrated into sophisticated retractor systems, handheld devices and intracavity drop-in illuminators; each utilizing our proprietary waveguide technology that directs and shapes light into broad, uniform illumination to provide enhanced direct visualization inside dark surgical cavities. In addition, it converts traditional thermally hot, concentrated light output to thermally cool volumetric illumination throughout the entire surgical cavity.
Transforming Minimal access Surgeries Through Advanced Visualization
Invuity is committed to leveraging advanced photonics technology to transform and create a new standard of care for minimal access surgery.
SAN FRANCISCO, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, announced today that company management is scheduled to present at the Cantor Fitzgerald Global Healthcare Conference on Tuesday, September 26, 2017 at 10:55 a.m. Eastern Time in New York City. A live, listen-only webcast of the presentation may be accessed by visiting the Events & Presentations section of the Company's website at www.invuity.com under Investors & Media. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the Company's website for 30 days following the ...Read More
SAN FRANCISCO, Aug. 30, 2017 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, announced today that healthcare industry leader Daniel Wolterman has been appointed to its Board of Directors, effective September 5, 2017. Wolterman was most recently President & Chief Executive Officer of Memorial Herman Healthcare System. "We are pleased to welcome Dan to Invuity’s Board of Directors," said Invuity Chief Executive Officer Philip Sawyer. "His significant insight into healthcare systems will be extremely valuable as we continue to grow our business by providing innovative product solutions to our hospital customers." W...Read More
Achieves revenue growth of 19% over prior year quarter Updates 2017 revenue guidance SAN FRANCISCO, July 25, 2017 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today reported financial results for the three months and six months ended June 30, 2017. Q2 2017 Highlights Revenue grew 19% to $9.8 million compared to revenue of $8.2 million in the 2016 second quarter. Approximately 825 hospitals purchased Invuity devices in the second quarter of 2017, up from 620 hospitals in the second quarter of 2016. Approximately 300,000 procedures have been performed using Invuity devices. "We continued to experienc...Read More
“Invuity’s Intelligent Photonics Technology is a must-have for all my surgical procedures, particularly lumpectomies, and skin and nipple sparing mastectomies. This technology enables me to make a single inframammary incision and clearly visualize deep into the surgical cavity all the way to the axilla. Additionally, it has enabled me to operate proficiently, improving the viability of the breast flap. I have reduced my surgical times while improving patient safety and aesthetic outcomes.”
Director, Comprehensive Breast Care Surgeons
Medical Director, Breast Health Program
Holy Redeemer Health System
“It is not often you see new technology or medical devices and know how much you will like it and the impact it will make before you even use it! That is exactly what happened with Invuity’s Eikon Illuminated Retractor System.”
The dynamic fluorescence imaging of the PhotonVue allows me to confidently offer more advanced nipple sparing mastectomy techniques and single stage procedures to a broader patient population. Specifically, confirming tissue perfusion during the reconstruction enables me to discuss these techniques with patients who are smokers, diabetics, those who were previously radiated or have high BMIs.
Director of Bucks County Aesthetic Center – Bensalem, PA